186 related articles for article (PubMed ID: 26864029)
21. Critical roles of inflammation and apoptosis in improved survival in a model of hyperoxia-induced acute lung injury in Pneumocystis murina-infected mice.
Beck JM; Preston AM; Wilcoxen SE; Morris SB; Sturrock A; Paine R
Infect Immun; 2009 Mar; 77(3):1053-60. PubMed ID: 19124601
[TBL] [Abstract][Full Text] [Related]
22. The absence of Hck, Fgr, and Lyn tyrosine kinases augments lung innate immune responses to Pneumocystis murina.
Nelson MP; Metz AE; Li S; Lowell CA; Steele C
Infect Immun; 2009 May; 77(5):1790-7. PubMed ID: 19255189
[TBL] [Abstract][Full Text] [Related]
23. Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.
Kelly MN; Zheng M; Ruan S; Kolls J; D'Souza A; Shellito JE
J Immunol; 2013 Jan; 190(1):285-95. PubMed ID: 23203926
[TBL] [Abstract][Full Text] [Related]
24. Immunization with Pneumocystis carinii A12
Tong T; Wang Z; Xu Y; Shen J
BMC Immunol; 2021 Jun; 22(1):40. PubMed ID: 34174820
[TBL] [Abstract][Full Text] [Related]
25. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.
Harmsen AG; Chen W; Gigliotti F
Infect Immun; 1995 Jul; 63(7):2391-5. PubMed ID: 7790048
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in
Eddens T; Elsegeiny W; Ricks D; Goodwin M; Horne WT; Zheng M; Kolls JK
mSphere; 2019 Sep; 4(5):. PubMed ID: 31484742
[No Abstract] [Full Text] [Related]
27. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization.
Smulian AG; Sullivan DW; Theus SA
Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685
[TBL] [Abstract][Full Text] [Related]
28. Effect on parasite eradication of Pneumocystis carinii-specific antibodies produced in the presence or absence of CD4(+) alphabeta T lymphocytes.
Hanano R; Kaufmann SH
Eur J Immunol; 1999 Aug; 29(8):2464-75. PubMed ID: 10458760
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection.
Rudner XL; Happel KI; Young EA; Shellito JE
Infect Immun; 2007 Jun; 75(6):3055-61. PubMed ID: 17403873
[TBL] [Abstract][Full Text] [Related]
30. B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.
Opata MM; Hollifield ML; Lund FE; Randall TD; Dunn R; Garvy BA; Feola DJ
J Immunol; 2015 Jul; 195(2):611-20. PubMed ID: 26041535
[TBL] [Abstract][Full Text] [Related]
31. Dectin immunoadhesins and pneumocystis pneumonia.
Ricks DM; Chen K; Zheng M; Steele C; Kolls JK
Infect Immun; 2013 Sep; 81(9):3451-62. PubMed ID: 23836814
[TBL] [Abstract][Full Text] [Related]
32. STAT4-dependent and -independent Th2 responses correlate with protective immunity against lung infection with Pneumocystis murina.
Myers RC; Dunaway CW; Nelson MP; Trevor JL; Morris A; Steele C
J Immunol; 2013 Jun; 190(12):6287-94. PubMed ID: 23650614
[TBL] [Abstract][Full Text] [Related]
33. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.
Rapaka RR; Ricks DM; Alcorn JF; Chen K; Khader SA; Zheng M; Plevy S; Bengtén E; Kolls JK
J Exp Med; 2010 Dec; 207(13):2907-19. PubMed ID: 21149550
[TBL] [Abstract][Full Text] [Related]
34. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
Bishop LR; Helman D; Kovacs JA
BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748
[TBL] [Abstract][Full Text] [Related]
35. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.
Gigliotti F; Wiley JA; Harmsen AG
Infect Immun; 1998 Jul; 66(7):3179-82. PubMed ID: 9632583
[TBL] [Abstract][Full Text] [Related]
36. Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection.
Kling HM; Norris KA
J Infect Dis; 2016 May; 213(10):1586-95. PubMed ID: 26823337
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary Interleukin-17-Positive Lymphocytes Increase during Pneumocystis murina Infection but Are Not Required for Clearance of Pneumocystis.
Ripamonti C; Bishop LR; Kovacs JA
Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28438973
[No Abstract] [Full Text] [Related]
38. Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.
Linke MJ; Ashbaugh AA; Koch JV; Levin L; Tanaka R; Walzer PD
J Eukaryot Microbiol; 2009; 56(1):58-65. PubMed ID: 19335775
[TBL] [Abstract][Full Text] [Related]
39. In vitro effector activity of Pneumocystis murina-specific T-cytotoxic-1 CD8+ T cells: role of granulocyte-macrophage colony-stimulating factor.
McAllister F; Steele C; Zheng M; Shellito JE; Kolls JK
Infect Immun; 2005 Nov; 73(11):7450-7. PubMed ID: 16239546
[TBL] [Abstract][Full Text] [Related]
40. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice.
Christensen PJ; Preston AM; Ling T; Du M; Fields WB; Curtis JL; Beck JM
Infect Immun; 2008 Aug; 76(8):3481-90. PubMed ID: 18490462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
